ClotCare is a member organization of the Coalition to Prevent Deep Vein Thrombosis. Click here to learn more about the Coalition to Prevent Deep Vein Thrombosis and DVT Awareness Month, which is held each March.

A recent study published in The American Journal of Cardiology is a retrospective cost analysis of post-operative anticoagulation in 63 patients undergoing valve replacement surgery. Compared to unfractionated heparin, post operative low molecular weight heparin therapy was associated with significantly lower post-operative costs, primarily attributed to reduced length of stay. No differences in clinical outcomes, including bleeding, thromboembolic events, or 90 day mortality, were observed.